http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5993018-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 1982-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_340332fdabc22d37cbb000917bb7a743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeaf7ae13cfab3856c1bdcee58c9eb0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c475ebef15eccdd3111ea20f4155ac9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d458a23e24e7d679a980a56740077c0 |
| publicationDate | 1984-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S5993018-A |
| titleOfInvention | Remedy for facial paresthesia |
| abstract | PURPOSE: To drug, containing ethyl aminobenzoate as a principal constituent, and useful for treating facial paresthesia caused by pyrethroid compounds. n CONSTITUTION: A remedy, containing ethyl aminobenzoate as a principal constituent, e.g. α-cyano-3-phenoxybenzyl-2-(4-chlorophenyl)isovalerate, and useful for treating facial paresthesia caused by pyrethroid compounds. The facial paresthesia indicates a transient abnormal facial sensation such as a sensation of smarting, crawling, pricking or burning in the face, particularly a part below the eyes, and is reported to occur in synthesizing research or formulating processes, etc. of the various pyrethroid compounds. The ethyl aminobenzoate exhibits a remarkable remedial effect on the above-mentioned symptoms. The remedy is generally used by application to the affected part, and the pharmaceutical form thereof is preferably an ointment. The content of the principal constituent in the drug is usually 1W5%. n COPYRIGHT: (C)1984,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003298710-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008084670-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004047819-A3 |
| priorityDate | 1982-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.